ESC Premium Access

Revascularization decisions in patients with stable angina and intermediate lesions: results of the second International Survey on Interventional Strategy (ISIS-2)

Congress Presentation

About the speaker

Doctor Gabor Toth

Medical University of Graz, Graz (Austria)
3 presentations
0 follower

6 more presentations in this session

Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017

Speaker: Associate Professor M. Leosdottir (Malmo, SE)


Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach

Speaker: Professor R. Storey (Sheffield, GB)


Identifying high thrombotic risk in atrial fibrillation patients undergoing percutaneous coronary intervention: is there a benefit of triple therapy?

Speaker: Mr W. Bor (Nieuwegein, NL)


Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Speaker: Doctor T. Vanassche (Leuven, BE)


Ten-year all-cause death in elderly patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A prespecified subgroup analysis of the SYNTAX Extended Survival study

Speaker: Doctor M. Ono (Amsterdam, NL)


Access the full session

Optimizing Management of Chronic CAD – Squeeze on Big Data for Additional Info

Speakers: Doctor G. Toth, Associate Professor M. Leosdottir, Professor R. Storey, Mr W. Bor, Doctor T. Vanassche...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb